Richard Justice
Direttore Finanziario/CFO presso Mie Pay Ltd.
Profilo
Richard Justice is currently the Chief Financial Officer at Mie Pay Ltd.
He previously worked as a Secretary at New Talisman Gold Mines Ltd., and as the Chief Financial Officer at Algorae Pharmaceuticals Ltd.
and Photonz Corp.
Ltd.
Mr. Justice obtained an undergraduate degree and an MBA from Auckland University.
Posizioni attive di Richard Justice
| Società | Posizione | Inizio |
|---|---|---|
Mie Pay Ltd.
 Mie Pay Ltd. Packaged SoftwareTechnology Services Mie Pay Ltd. is a holding company, which engages in the provision of E-commerce and payments platform. The company was founded on November 1, 2018 and is headquartered in Sydney, Australia. | Direttore Finanziario/CFO | 04/11/2019 |
Precedenti posizioni note di Richard Justice
| Società | Posizione | Fine |
|---|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Direttore Finanziario/CFO | - |
| NEW TALISMAN GOLD MINES LIMITED | Segretario Aziendale | - |
Photonz Corp. Ltd.
 Photonz Corp. Ltd. BiotechnologyHealth Technology Photonz Corp. Ltd. operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid. Its products include PNZC0901, a fermentation drug substance comprising high purity eicosapentaenoic acid. The company was founded by Karl Thomas Geiringer on April 17, 2015 and is headquartered in Auckland, New Zealand. | Direttore Finanziario/CFO | - |
Formazione di Richard Justice
| Auckland University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Health Technology |
| NEW TALISMAN GOLD MINES LIMITED | Non-Energy Minerals |
 | Technology Services |
| Aziende private | 1 |
|---|---|
Photonz Corp. Ltd.
Photonz Corp. Ltd. BiotechnologyHealth Technology Photonz Corp. Ltd. operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid. Its products include PNZC0901, a fermentation drug substance comprising high purity eicosapentaenoic acid. The company was founded by Karl Thomas Geiringer on April 17, 2015 and is headquartered in Auckland, New Zealand. | Health Technology |
- Borsa valori
- Insiders
- Richard Justice
